JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4007 MLN9708
3 Citation

Target: Proteasome

Summary: Proteasome inhibitor

insoluble in H2O; ≥20.85 mg/mL
A2604 Celastrol

Target: Proteasome

Summary: Antioxidant, anti-inflammatory and immunosuppressive agent

≥22.55 mg/mL
A4083 Rocilinostat (ACY-1215)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: Selective HDAC6 inhibitor

≥21.675 mg/mL
A2583 Lactacystin (Synthetic)
1 Citation

Target: Proteasome

Summary: Proteasome inhibitor

Soluble in H2O
A2606 Epoxomicin
25 Citation

Summary: Proteasome inhibitor

≥27.73 mg/mL
A2585 MG-132
26 Citation

Target: Proteasome

Summary: Proteasome inhibitor, Cell permeable, reversible

≥23.78 mg/mL
A4010 Salinosporamide A (NPI-0052, Marizomib)

Target: Proteasome

Summary: 20S proteasome inhibitor

Soluble in DMSO
A2614 Bortezomib (PS-341)
24 Citation

Target: Proteasome

Summary: Proteasome Inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A1903 E 64d
4 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL
A4393 Paclitaxel (Taxol)
4 Citation

Target: Microtubules/Tubulins

Summary: Antineoplastic agent

≥85.6 mg/mL